Despite approval from Health Canada, delay in cancer drug funding leaves patients in limbo
Global - North America
Archived
•
June 30, 2026
•
A bespoke treatment for metastatic melanoma is unavailable to Canadians because it is still being reviewed for public funding
Source: https://www.theglobeandmail.com/arc/outboundfeeds/rss/category/canada/ - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



